Journal article
Oncotarget, vol. 7, 2016, pp. 79217--79232
APA
Click to copy
Liu, P. Y., Sokolowski, N., Guo, S. T., Siddiqi, F., Atmadibrata, B., Telfer, T. J., … Liu, T. (2016). The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects in combination with quinone-containing compounds and anti-microtubule drugs. Oncotarget, 7, 79217–79232. https://doi.org/10.18632/oncotarget.12640
Chicago/Turabian
Click to copy
Liu, P. Y., N. Sokolowski, S. T. Guo, F. Siddiqi, B. Atmadibrata, T. J. Telfer, Y. Sun, et al. “The BET Bromodomain Inhibitor Exerts the Most Potent Synergistic Anticancer Effects in Combination with Quinone-Containing Compounds and Anti-Microtubule Drugs.” Oncotarget 7 (2016): 79217–79232.
MLA
Click to copy
Liu, P. Y., et al. “The BET Bromodomain Inhibitor Exerts the Most Potent Synergistic Anticancer Effects in Combination with Quinone-Containing Compounds and Anti-Microtubule Drugs.” Oncotarget, vol. 7, 2016, pp. 79217–32, doi:10.18632/oncotarget.12640.
BibTeX Click to copy
@article{liu2016a,
title = {The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects in combination with quinone-containing compounds and anti-microtubule drugs},
year = {2016},
journal = {Oncotarget},
pages = {79217--79232},
volume = {7},
doi = {10.18632/oncotarget.12640},
author = {Liu, P. Y. and Sokolowski, N. and Guo, S. T. and Siddiqi, F. and Atmadibrata, B. and Telfer, T. J. and Sun, Y. and Zhang, L. and Yu, D. and McCarroll, J. and Liu, B. and Yang, R. H. and Guo, X. Y. and Tee, A. E. and Itoh, K. and Wang, J. and Kavallaris, M. and Haber, M. and Norris, M. D. and Cheung, B. B. and Byrne, J. A. and Ziegler, D. S. and Marshall, G. M. and Dinger, M. E. and Codd, R. and Zhang, X. D. and Liu, T.}
}